Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Researchers develop a novel murine model of Cockayne syndrome

Jan. 14, 2022

CD6-ALCAM pathway is a therapeutic target in SLE

Jan. 12, 2022

InflaRx advances oral C5aR inhibitor INF-904 toward clinic

Jan. 11, 2022

Modulating CYTOR promotes myogenesis in aging

Jan. 7, 2022

Kyverna licenses CAR T construct for use in autologous and allogeneic therapies

Jan. 4, 2022

New RIPK1 inhibitors discovered at Sanofi

Dec. 29, 2021

Noncanonical NLRC4 inflammasome mechanism offers new targets for sterile inflammatory disorders

Dec. 23, 2021

IL-27-producing natural regulatory B-1a cells protect from CNS autoimmune diseases

Dec. 22, 2021

Nanjing Chia Tai Tianqing Pharmaceutical divulges AXL inhibitors

Dec. 22, 2021

CAN-10 shows promise in systemic sclerosis model

Dec. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...